DAY 1 - October 10, 2010 |
|
Chairpersons: |
Dr. Waleed Al Shehhi
Consultant Rheumatologist
Chairperson, ESR
Dr. Humeira Badsha
Consultant Rheumatologist
Secretary, ESR |
| Track 1 |
SESSION ONE: Pain Management: |
| 8.30 |
Approach to a patient with Inflammatory arthritis : Recognise and treat Rheumatoid Arthritis:
Chairpersons: Dr. Bhavna Khan and Dr Irena Khostanteen |
|
9.00 |
Rheumatoid Arthritis: State of the Art Management in 2010
Prof. John Isaacs, Professor of Clinical Rheumatology, Newcastle University, UK |
| 9.40 |
Sensing the main health concerns in patients with established RA
Dr Haider Al Aitta, Consultant Physician in Internal Medicaine and Rheumatology, Al Noor Hospital UAE |
| 10.00 |
Rheumatic Diseases In Lebanon: A National Copcord Study
Imad Uthman, Professor of Clinical Medicine Head, Division of Rheumatology Department of Internal Medicine American University of Beirut. |
| 10.25 |
Q & A |
|
10.35 |
Lower Back Pain:
Chairpersons : Dr. Mohamed Almarzouqi and Dr Haider Al Attia
Lower Back Pain - recognise red flags, when to refer to the specialist
Dr Ayman Mofti, Director, Al Biraa Arthritis Clinic |
| 11.00 |
Lower back pain from a Chiropractors perspective
Dr Gerry Nastasia, Staff Clinician, Emirates Euorpan Medical Centre |
|
|
|
|
|
| 11.20 |
COFFEE BREAK |
|
|
|
SESSION TWO: Arthritis |
|
Chairpersons: Prof. Adel Alawadhi and Dr. Ferhana Najam |
| 11.40 |
Update on cox 2 inhibitors
Dr. Algis Jovaisas, President - Ontario Rheumatology Association. |
| 12.10 |
Vitamin D deficiency and the Rheumatic conditions
Dr Humeira Badsha, Consultant Rheumatologist, Al Biraa Arthritis Clinic, Dubai |
| 12.30 |
Perspectives in Psoriatic arthritis
Prof Oliver FitzGerald, Consultant Rheumatologist, Newman Clinical Research Professor at St Vincent's University Hospital, Ireland |
| 13.10 |
Q&A Session |
|
|
| 13.20 |
LUNCH |
|
|
| 14.20 |
Comorbidities and metabolic syndromes in spondyloarthropathies.
Dr Waleed AlShehhi, Consultant rheumatologist Al Biraa centre and Suliman AlHabib, President ESR |
| 14.40 |
Behcet's Disease
Thurayya Arayssi, MD, Associate Professor, Weill Cornell Medical College- QatarDr. Musa Al Hadidi, Jordan |
|
|
|
SESSION THREE: Osteoporosis
Chairpersons: Dr. Mustafa Al Izzi |
| 15.00 |
Advanced Therapy across the Spectrum of Patients with Osteoporosis
Prof David Reid, Professor of Rheumatology, Department of Medicine & Therapeutics, University of Aberdeen and Honorary Consultant Rheumatologist, GUHT |
| 15.25 |
Osteoporosis & Rheumatic Diseases: Diagnosis & Treatment
Basel Masri, MD, Consultant Rheumatologist, Jordan Hospital, Amman Jordan |
| 15.50 |
Update on Osteoporosis:Disease and Management
Dr David Hosking,Consultant Physician Nottingham City Hospital, UK |
|
|
|
|
| 16.20 |
COFFEE BREAK |
|
|
|
SESSION FOUR: Meet the Professor |
| 16.40 |
Meet the Professor: Difficult to treat Sceroderma
Prof. Marco Matucci, Professor of Rheumatology and Medicine and Director of Division of Medicine and Rheumatology, University of Florence, Italy |
| 17.20 |
Meet the Professor session: Ankylosing Spondylitis
Oliver FitzGerald Consultant Rheumatologist, Newman Clinical Research Professor at St Vincent's University Hospital, Ireland |
| Track 2 |
WORKSHOPS |
|
10.00-13.15 |
Musco-skeletal Ultrasound Workshop for the Specialist (NON CME Accredited)
Prof Walter Grassi,
Waleed Al Shehhi |
| 16.20 |
Joint Injection Workshop for GP's
DBAJ
Dr. William D. Murrell, Jr, MD
Orthopedic Sports Medicine Surgeon
Dr. Zbiggy J. Brodzinsky, MD
Orthopedic Spinal Surgeon |
DAY 2 - October 11, 2010 |
| Track 1 |
|
| 8.00 |
ABSTRACT PRESENTATION (NON- CME ACCREDITED)
Selection Committee
Dr Mohammed Hammoudeh, Consultant Rheumatologist, Hamed Medical Corporation, President, Rheumatology Society Qatar
Prof. Rohini Handa, President, Indian Rheumatology, Association, Senior Consultant Rheumatologist Apollo, Indraprastha Hospitals, New Delhi, India
Dr. Ayman Mofti, Director, Al Biraa Arthritis Clinic
Dr Imad Uthman, Professor of Clinical Medicine, Head, Division of Rheumatology, American University of Beirut, Lebanon. |
|
SESSION ONE: Rheumatoid Arthritis around the World
Chairpersons: Dr. Mustafa Al Maini and Dr. Khaled Al Muntasar |
| 9.00 |
Biologics in RA - The South Asian perspective
Prof. Rohini Handa, President, Indian Rheumatology Association, India. |
| 9.40 |
Optimizing the use of Methotrexate in Rheumatoid arthritis
Prof. Mohammed Hammoudeh, Consultant Rheumatologist, Hamed Medical Corporation, President, Rheumatology Society, Qatar |
| 10.15 |
RA Lecture – International Case Study
Prof. Josef Smolen, Chairman of the Department of Rheumatology Internal Medicine III Medical University of Vienna, Austria |
| 10.50 |
Reactivation of latent tuberculosis infection in patients receiving anti TNF -@therapy. Is it more of a cause for concern in Arab patients?
Dr. Mustafa Al Izzi Secretary Emirates Osteoporosis Society, Consultant Rheumatologist, Zayed Military Hospital |
| 11.20 |
ABSTRACT AWARDS PRESENTATION CEREMONY (NON-CME ACCREDITED)
|
| 11.20 |
COFFEE BREAK |
| 11.45 |
SESSION TWO: Meet The Professors
Difficult to treat RA
Professor John Isaacs, Professor of Clinical Rheumatology, Newcastle University, UK |
| 12.30 |
Meet the Professor: Differentiating between Rheumatoid Arthritis and Osteoarthritis through ultrasound (NON CME Accredited)
Prof Walter Grassi, Director of the Postgraduate School in Rheumatology, Marche Polytechnic University, Italy |
| 13.00 |
MSD SYMPOSIUM (NON CME ACCREDITED)
Prof Josef Smolen
Prof Mohammed Hammoudeh
Dr. Samar A l-Emadi
Dr. Mustafa Al Miani |
|
|
| 14.00 |
MSD Sponsored LUNCH |
|
Session 2: Lupus & Other Tissue Diseases
Chairpersons: Dr. Shehata El Khouly |
| 15.00 |
SLE - The Malaysian Experience
Dr. Swan Sim Yeap, Consultant Rheumatologist, Sime Darby Medical Centre Subang Jaya, Malaysia |
| 15.30 |
State-of-the-art SLE
Prof. Graham Hughes, HCA International Hospitals, UK |
| 16.10 |
Medical Emergencies in SLE
Sami Salman, University of Baghdad, Iraq |
|
|
| 16.30 |
COFFEE BREAK |
|
|
| 16.50 |
Methylprednisolone treatment in SLE: Evidence- Based Approach
Dr. Mustafa Al Maini, Chief of Rheumatology, Clinical Immunology and Allergy Division at Mafraq Hospital, Abu Dhabi |
| 17.20 |
Ankylosing Spondylitis
Dr. Samar A l-Emadi |
| 20.00 |
PZFIZER SYMPOSIUM BY INVITATION ONLY |
DAY 3 - October 12, 2010 (NON CME Accredited)
FREE TO ATTEND FORUM FOR PATIENTS AND INSURANCE COMPANIES
Join the Debate: Focus for Insurance companies and Health care Policymakers to reduce the burden of Arthritis |
|
Chair: Dr Haider (rheumatologist) – What is Arthritis and the advent of biologic treatment |
|
|
| |
Introduction: EAF, why we are doing this conference
Katrina Thornley, Patient Support Director, Emirates Arthritis Foundation |
|
International Speaker: (TBC) The benefits of early treatment with biologics, for the disease activity and implications (TBC) |
| |
Patient: Case history who has been successful on biologic treatment |
|
Patient: Case history who is unable to receive biologic medication due to lack of insurance. |
|
Insurance Spokesperson: (TBC) Guidelines from the insurance companies for biologics. How doctors can cooperate from the perspective of the Insurance industry (TBC) |
|
Dubai Health Authority or Ministry of Health: - How these bodies can help and could help |
|
Closing comments
Panel: (TBC) |